Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Disorders of the Nervous System

Progressive Changes in Sleep and Its Relations to Amyloid-β Distribution and Learning in Single App Knock-In Mice

Sakura Eri B. Maezono, Mika Kanuka, Chika Tatsuzawa, Miho Morita, Taizo Kawano, Mitsuaki Kashiwagi, Pimpimon Nondhalee, Masanori Sakaguchi, Takashi Saito, Takaomi C. Saido and Yu Hayashi
eNeuro 22 April 2020, 7 (2) ENEURO.0093-20.2020; DOI: https://doi.org/10.1523/ENEURO.0093-20.2020
Sakura Eri B. Maezono
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
2PhD Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sakura Eri B. Maezono
Mika Kanuka
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chika Tatsuzawa
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miho Morita
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taizo Kawano
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuaki Kashiwagi
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
3Doctoral Programs in Kansei, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pimpimon Nondhalee
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanori Sakaguchi
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masanori Sakaguchi
Takashi Saito
4Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan
5Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Science, Nagoya, Aichi 467-8601, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takaomi C. Saido
4Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Takaomi C. Saido
Yu Hayashi
1International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
2PhD Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
3Doctoral Programs in Kansei, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Alzheimer’s disease (AD) patients often suffer from sleep disturbances. Alterations in sleep, especially rapid eye movement sleep (REMS), can precede the onset of dementia. To accurately characterize the sleep impairments accompanying AD and their underlying mechanisms using animal models, it is crucial to use models in which brain areas are affected in a manner similar to that observed in the actual patients. Here, we focused on AppNL-G-F mice, in which expression levels and patterns of mutated amyloid precursor protein (APP) follow the endogenous patterns. We characterized the sleep architecture of male AppNL-G-F homozygous and heterozygous mice at two ages (six and 12 months). At six months, homozygous mice exhibited reduced REMS, which was further reduced at 12 months together with a slight reduction in non-REMS (NREMS). By contrast, heterozygous mice exhibited an overall normal sleep architecture. Homozygous mice also exhibited decreased electroencephalogram γ to δ power ratio during REMS from six months, resembling the electroencephalogram slowing phenomenon observed in preclinical or early stages of AD. In addition, homozygous mice showed learning and memory impairments in the trace fear conditioning (FC) at both ages, and task performance strongly correlated with REMS amount at 12 months. Finally, histologic analyses revealed that amyloid-β accumulation in the pontine tegmental area and ventral medulla followed a course similar to that of the REMS reduction. These findings support the notion that changes in REMS are an early marker of AD and provide a starting point to address the mechanism of sleep deficits in AD and the effects on cognition.

  • Alzheimer’s disease
  • brainstem
  • electroencephalogram
  • learning and memory
  • mouse
  • sleep

Significance Statement

Sleep impairments are major non-cognitive symptoms in Alzheimer’s disease (AD). Moreover, recent animal studies provide strong support that insufficient sleep accelerates neurodegeneration. Towards elucidating how and why sleep is impaired in AD using animal models, minimizing artefacts due to overexpressing or ectopically expressing App is crucial. Here, we addressed the effects of singly knocking in the human App gene carrying mutations associated with familial AD into the mouse App locus. The mutations lead to progressive changes in rapid eye movement sleep (REMS), which correlated with memory deficits and amyloid-β distribution in the brainstem, thus pointing out the importance of studying REMS in understanding AD-associated sleep impairments. In addition, EEG alterations during REMS appeared earlier than during wake, which might be beneficial as biomarkers.

Introduction

Alzheimer’s disease (AD) is a slowly progressing neurodegenerative disease characterized by extracellular amyloid-β (Aβ) deposits, intracellular neurofibrillary tangles, and neuronal loss. In addition to cognitive impairments, sleep disturbances commonly occur in patients with AD (Carpenter et al., 1996; McCurry et al., 1999). Sleep impairments can exacerbate a decline in the quality of life, not only of the patients with AD, but also that of the caregivers (Moran et al., 2005). Moreover, recent studies in humans and animal models revealed that sleep deprivation or fragmentation accelerates Aβ accumulation and may thus contribute to the progression of AD (Kang et al., 2009; Minakawa et al., 2017; Shokri-Kojori et al., 2018). This notion is further supported by recent findings that alterations in sleep are present before the onset of AD (Ju et al., 2013; Pase et al., 2017).

In attempts to characterize the sleep disturbances accompanying AD and to elucidate the underlying mechanisms, many studies have conducted sleep recordings in various mouse models of AD (Jyoti et al., 2010; Platt et al., 2011; Roh et al., 2012; Schneider et al., 2014; Colby-Milley et al., 2015; Sethi et al., 2015; Kent et al., 2018). The mouse models used in these studies, however, either carry multiple copies of App or presenilin or use heterologous promoters to express these genes, which likely leads to overexpression or ectopic expression of amyloid precursor protein (APP) or presenilin, factors that contribute to the generation of Aβ from APP. The phenotypes of such AD mouse models may be due in part to an unintended consequence of the overexpression. Moreover, sleep/wake states are regulated by the interactions of various brain areas, and ectopic expression of APP or presenilin may affect such interactions and alter sleep in a largely different manner than in patients with the actual disease.

To overcome these concerns, we focused on the AppNL-G-F mouse, a recently developed mouse model of AD in which a mutated human version of App is singly knocked into the original App locus (Saito et al., 2014). In these mice, the humanised App sequence contains three mutations that are associated with familial AD: the Swedish (NL), Beyreuther/Iberian (F), and Arctic (G) mutations. These mice do not exhibit elevated expression of APP, but do exhibit a progressive increase in the accumulation of Aβ, a higher ratio of Aβ42 to Aβ40, amyloidosis, and neuroinflammation in several brain areas (Saito et al., 2014).

To evaluate how the sleep architecture and state-dependent oscillatory brain activities are affected in AppNL-G-F heterozygous and homozygous mice, we recorded the EEG and EMG from these mice at multiple ages. Furthermore, to gain insight into the brain areas responsible for the altered sleep patterns, amyloidosis was assessed in several subcortical areas involved in sleep regulation. In addition, to investigate the relationship between the development of sleep disturbances and cognitive impairment, we assessed the learning and memory abilities in these mice and analyzed the correlation between their performance in the behavioral tasks and sleep parameters.

Materials and Methods

Animals

Male and female AppNL-G-F/wt mice on a C57BL/6J background were crossed to obtain male AppNL-G-F/wt, AppNL-G-F/NL-G-F, and control wild-type (WT) mice for analyses. The mice were group housed under a 12/12 h light/dark cycle (lights on at 9 A.M.) under controlled temperature (23.5 ± 2.0°C) and humidity conditions (51.0 ± 10.0%) with free access to water and food. The mouse facility was SPF grade, and solid plastic cages (CLEA Japan) and paper chip bedding (Sankyo Labo Service Corp.) were used. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Tsukuba, and all procedures were conducted in accordance with the Regulations for Animal Experiments of the University of Tsukuba.

Behavioral tests

Male mice underwent the open field test (OFT) and trace fear conditioning (FC) test, which are described in detail below. Before each behavioral test, the mice were each handled for 4 d (2 min × two times on the first day and 2 min × three times for the next 3 d) according to a previous study (Purple et al., 2017). The orders in which mice of different genotypes underwent behavioral experiments were randomized. During the experimental procedures and subsequent data analyses, the experimenter was blinded to the genotype.

OFT

The OFT was performed as described in a previous study (Seibenhener and Wooten, 2015) with some modifications. Briefly, mice were individually placed in an acrylic box (40 × 40 × 40 cm) and the activity was monitored by a video camera positioned centrally above the box. Each session lasted 10 min per mouse and was performed between zeitgeber time (ZT) 3:00 and 5:00. Light intensity was fixed at 70 lx and white noise (80 dB) was applied. Video files were analyzed using the SMART Video Tracking software v3 (PanLab/Harvard Apparatus). The open field was divided into 16 equivalent square areas and the four inner squares were considered the central zone.

Trace FC

The trace FC test was performed as previously described (Chowdhury et al., 2005; Purple et al., 2017) with some modifications. On day 1, mice were trained between ZT 8:30 and 9:30. The training context (context A) was a chamber (31 × 24 × 21 cm) equipped with a stainless steel shock grid floor, as previously described (Arruda-Carvalho et al., 2011). After 192 s in context A, each mouse received five sets of conditioned stimulus (CS)-unconditioned stimulus (US) pairs. The CS was a 20-s tone (∼80 dB) and the US was a 2-s foot shock (0.75 mA). The CS and US were separated by a 10-s trace period. Between each set, there was a 180-s interval. Mice remained in the same context for an additional 180 s before being returned to their home cage. On day 2, a retrieval test was performed between ZT 6:00 and 8:00. Mice were placed in a novel environment (context B), which was an acrylic box (570 × 370 × 185 cm) wrapped outside with black paper sheets. After 192 s in context B, the CS was presented. During both the training and the retrieval test, mouse activity was monitored by a video camera to calculate the freezing rate. On day 1, the responsivity to the shock stimulus was assessed as described in our previous study (Purple et al., 2017) with some modifications. Briefly, the distance of the mouse movement 2 s before and during the first shock presentation was measured using Freezeframe4 (Actimetrics Software), which digitized the video signal at ∼10 Hz and allowed for measurement of the movement frame by frame. Mice were judged as exhibiting freezing behavior if no movement except for that related to respiration was detected for at least 1 s by an experimenter blinded to the genotype.

EEG/EMG recording and analyses

Male mice were subjected to EEG/EMG recording to characterize the sleep architecture. To implant EEG and EMG electrodes, the mice were anaesthetized with isoflurane and placed in a stereotaxic frame (Leica Angle Two, Leica Microsystems Inc.). Core body temperature was maintained using a feedback-controlled heating pad. EEG electrodes were stainless steel recording screws implanted epidurally over the parietal cortex (3 mm posterior to bregma, 1.5 mm lateral to the midline) and cerebellum (6.5 mm posterior to bregma, 2 mm lateral to the midline). EMG electrodes were stainless steel Teflon-coated wires placed bilaterally into nuchal muscles. The electrodes were fixed to the skull with the resin cement (Super-Bond C&B set; Sun Medical). The mice were allowed to recover in their home cages for two weeks before being transferred to the sleep recording chambers. The mice were attached to the recording cables and acclimatized to the recording chamber for at least 5 d. Following 48 h of EEG/EMG recording under basal conditions, novel objects (marbles) were presented and EEG/EMG was recorded for an additional 4 h. The EEG/EMG data were amplified and filtered (band pass 0.5–250 Hz), digitized at a sampling rate of 512 Hz, and collected using VitalRecorder (Kissei Comtec).

The EEG signals were subjected to fast Fourier transform and further analysis using SleepSign (Kissei Comtec). The vigilance state in each epoch was manually classified as rapid eye movement sleep (REMS), non-REMS (NREMS), or wakefulness, on the basis of the EEG patterns as well as the absolute δ (1–4 Hz) power, the θ (7–10 Hz) power to δ power ratio, and the integral of the EMG signals. Epochs with high EMG and low δ power were classified as wakefulness. Epochs with high δ power and low EMG were classified as NREMS. Epochs with even lower EMG (suggestive of muscle atonia) and a high θ power to δ power ratio were classified as REMS. If a single epoch contained multiple states, the state with the highest occupancy was assigned. The epochs were 4 s long. In calculating the EEG power spectrum of REMS, NREMS, or wakefulness, the EEG power of each frequency bin was expressed as a percentage of the mean total EEG power over all frequency bins (1–50 Hz) across 24 h. All manual scoring was performed by an experimenter blinded to the genotype.

Immunohistochemistry

Following transcardial perfusion with 0.1 m PBS, dissected brains were postfixed with 4% paraformaldehyde/PBS overnight, equilibrated with 30% sucrose/PBS, and sectioned at 40 μm using a microtome (Yamato Kohki). The sections were washed with distilled water and placed in 0.3% H2O2/MeOH for 30 min and washed with distilled water again. After washing with 1× TBS (pH 7.5) + 0.1% Tween 20 (TBST) and incubating for 30 min in Tris-NaCl-blocking buffer (1× TBS + 0.5% Blocking Reagent; PerkinElmer; FP1020), the sections were incubated with a primary antibody for choline acetyltransferase (ChAT; 1:100 goat anti-ChAT; EMD Millipore; AB144P) at room temperature overnight and washed three times with TBST. The sections were then incubated with a primary antibody for Aβ [1:1000 mouse anti-human Aβ (N; 82E1) IgG; IBL; 10 323] at 4°C overnight. The sections were washed three times with TBST and incubated with secondary antibodies for ChAT [1:500 donkey anti-goat IgG-Alexa Fluor 546; Invitrogen; A-11056] and Aβ [1:1000 donkey anti-mouse horseradish peroxidase; Abcam; ab7061] combined with 1 μg/ml 4’,6-diamidino-2-phenylindole for 120 min. After washing four times in TBST, the sections were incubated with fluorescein-tyramide reagent (PerkinElmer; SAT701001KT) for 30 min and then washed four times in TBST. All sections were mounted on a slide glass using Immu-Mount (Thermo Scientific Shandon; 9990412). Images of the brain sections were obtained with a digital slide scanner (NanoZoomer XR, Hamamatsu Photonics). Quantification of Aβ-derived signals was performed as described in a previous study (DeVos et al., 2018) with some modifications. Briefly, the regions of interest were set manually using a freehand selection tool by an experimenter blinded to the genotype. Images were then processed using an ImageJ-based algorithm (DeVos et al., 2018) with some modifications. For each individual mouse, the calculated mean plaque area from, typically, three to four coronal sections (at least two sections) was considered the plaque area for each brain region of that mouse. For the medial septum-diagonal band of Broca (MSDB), the ChAT-positive area was chosen within this region from coronal sections between bregma 1.10 mm and 0.62 mm. For the pons, the tegmental area dorsal to the motor trigeminal nucleus and ventral to the cuneiform nucleus in coronal slices between bregma −4.84 and −5.34 mm was selected. For the medulla, the area ventromedial to either the facial nucleus or the ambiguous nucleus in coronal slices between bregma −6.34 and −6.84 mm was selected.

Experimental design and statistical analyses

The experimenters performing the data analyses were blinded to the genotype when scoring or analysing EEG/EMG, behavioral, or histologic data. Statistical analyses were performed using SPSS (IBM Corp.), PRISM 8 (GraphPad Software), or R statistical software (http://www.r-project.org/). Bar graphs and line graphs represent mean ± standard error of the mean (SEM). Each point on the bar graphs and scatter plots represents an individual mouse. For comparisons among three groups with multiple timepoints/trials, mixed ANOVA and post hoc Games–Howell multiple comparison test were applied. Otherwise, Games–Howell multiple comparison test or Welch’s t test was applied for comparisons among three or two groups, respectively. For correlation analyses, Pearson’s correlation coefficient (r) and the p value were calculated. Where applicable, all statistical tests were two-tailed. Significance was set at p < 0.05. Details on sample sizes and results of statistical tests are described in Extended Data.

Results

To assess the sleep architecture, learning abilities, and Aβ plaque distribution in AppNL-G-F/wt and AppNL-G-F/NL-G-F mice at multiple ages, two independent mouse groups were subjected to experiments with different timelines. For each of the two groups, sleep recording was performed at six months or 12 months of age. After the sleep recording, trace FC was performed at seven or 13 months of age. When mice were further subjected to histologic analyses, the mice were immediately killed by an overdose of anesthesia following trace FC to avoid any long-term effects of the fear experience.

In addition, OFT was performed to evaluate anxiety and locomotor activity at four or nine months (Fig. 1A,B). At neither age did heterozygous or homozygous mice display overt anxiety-like behavior, as reflected by a decrease in the time spent in the central zone (Fig. 1A), or decreased locomotion according to the total distance traveled (Fig. 1B). The body weight of heterozygous and homozygous mice also appeared equivalent to that of WT controls at all tested ages (Fig. 1C).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Normal OFT performance and body weight in AppNL-G-F/wt and AppNL-G-F/NL-G-F mice. A, B, Time spent in the central zone (A) and total distance traveled (B) by four- and nine-month-old mice. Bar graphs represent mean ± SEM. Each point represents an individual mouse. C, The body weight of the younger mice was measured at five and six months while the body weight of the older mice was measured at seven, nine, and 12 months. Each point represents the mean ± SEM. Detailed results of the statistical tests are described in Extended Data Figure 1-1.

Extended Data Figure 1-1

Detailed results of the statistical analyses in Figure 1. Download Figure 1-1, XLSX file.

Progressive deterioration of sleep architecture in single App knock-in mice

The sleep architecture of AppNL-G-F/wt, AppNL-G-F/NL-G-F, and control WT mice was compared using 24-h recordings of EEG and EMG at either six or 12 months of age (Fig. 2). At six months, a reduction of the total time in REMS and in the REMS/total sleep ratio was detected in homozygous mice (Fig. 2C). This reduction in the total time spent in REMS was mostly attributed to changes in the light phase (resting phase; Fig. 2A,D,E). A decrease in the number of wake and NREMS episodes was also observed (Fig. 2F). At 12 months, a further reduction in the total time spent in REMS and the REMS/total sleep ratio was detected in the homozygous mice (Fig. 2C), together with a shorter mean episode duration (Fig. 2G). Again, the reduction in the total time spent in REMS was mostly attributed to changes in the light phase (Fig. 2B,D,E). In addition, a decrease in the total time spent in NREMS and an increase in the total time spent awake was observed at this age (Fig. 2C). In contrast to REMS, the change in the amount of wake and NREMS seemed to arise from changes in the dark phase (active phase; Fig. 2D,E). For the wake state, the mean episode duration was increased, whereas for NREMS, the number of episodes was decreased (Fig. 2F,G). REMS latency was not affected at six or 12 months (Fig. 2H). The sleep architecture of heterozygous mice was grossly similar to that of the age-matched WT control mice at both six and 12 months (Fig. 2).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

AppNL-G-F/NL-G-F mice exhibit age-dependent impairments in sleep architecture. A, B, Diurnal sleep-wake cycles of six-month-old (A) and 12-month-old (B) mice. Each point represents the mean ± SEM; #p < 0.05, ###p < 0.001, mixed ANOVA; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, post hoc Games–Howell multiple comparison test. C–E, Total amount of wake, NREMS, REMS, and ratio of REMS to total sleep [24 h (C), light period (D), and dark period (E)]. F, G, Number of episodes (F) and mean episode duration (G) in each stage of wake, NREMS, and REMS. H, REMS latency. Bar graphs represent the mean ± SEM. Each point represents an individual mouse; *p < 0.05, **p < 0.01, ***p < 0.001, Games–Howell multiple comparison test. Detailed results of the statistical tests are described in Extended Data Figure 2-1.

Extended Data Figure 2-1

Detailed results of the statistical analyses in Figure 2. Download Figure 2-1, XLSX file.

Alterations of brain oscillatory activities during sleep in single App knock-in mice

The brain exhibits oscillatory activities across various frequencies with distinct patterns depending on the vigilance state. Such oscillatory activities are thought to play important roles in information processing and are altered in many neuronal diseases, including AD, with distinct characteristics depending on the disease (Herrmann and Demiralp, 2005; Koenig et al., 2005). In AD, alterations in the oscillatory activities are most readily detected during REM sleep, with a decrease in high-frequency oscillations accompanied by an increase in low-frequency oscillations (Prinz et al., 1992; Petit et al., 1993). These alterations are also detected in subjects with mild cognitive impairment, suggesting that the alterations emerge from the preclinical stage of AD (Brayet et al., 2016). To investigate whether brain oscillatory changes occur in AppNL-G-F/wt and AppNL-G-F/NL-G-F mice, the power spectra of EEG obtained at different vigilance states were compared between genotypes at six and 12 months (Fig. 3). At six months, the homozygous mice had a significantly higher δ power during REMS compared with WT, whereas the δ power during NREMS was not affected (Fig. 3D,E). By contrast, during NREMS, θ power was significantly lower in the homozygous mice (Fig. 3G). For both sleep stages at six months, although not significant, there was a trend toward decreased γ power in the homozygous mice (Fig. 3J,K). At 12 months, the oscillatory activity during sleep was further affected in the homozygous mice. During both sleep stages, δ power was significantly increased, whereas θ and γ power were significantly decreased (Fig. 3D,E,G,H,J,K). Oscillatory activity during the wake state was less affected in the homozygous mice. θ And γ power appeared normal at both ages, whereas δ power was increased (Fig. 3C,F,I).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

AppNL-G-F/NL-G-F mice exhibit age-dependent alterations in brain oscillatory activities. A, B, EEG power spectrum of wakefulness, NREMS, and REMS in six-month-old (A) and 12-month-old (B) mice. C–K, Comparison of δ (1–4 Hz) power (C–E), θ (7–10 Hz) power (F–H), and γ (25–45 Hz) power (I–K) during wake (C, F, I), NREMS (D, G, J), and REMS (E, H, K). L–N, Ratio of γ to δ power during wake (L), NREMS (M), and REMS (N). O, Ratio of θ to δ power during REMS. Bar graphs represent mean ± SEM. Each point represents an individual mouse; *p < 0.05, **p < 0.01, ***p < 0.001, Games–Howell multiple comparison test. Detailed results of the statistical tests are described in Extended Data Figure 3-1.

Extended Data Figure 3-1

Detailed results of the statistical analyses in Figure 3. Download Figure 3-1, XLSX file.

Considering the reported decrease in high-frequency oscillations and the increase in low-frequency oscillations in patients with early AD, we next compared the ratio of fast oscillatory (γ) power to slow oscillatory (δ) power. The ratio was significantly lower during REMS in the homozygous mice at six months, when the ratio appeared unaffected during wake or NREMS (Fig. 3L,M,N). In addition, the ratio of θ power to δ power during REMS was reduced in the homozygous mice (Fig. 3O).

Sleep under novel object presentation

Human sleep is often affected by external stimuli. Exposing rodents to novel objects also affect their sleep (Schiffelholz and Aldenhoff, 2002). Therefore, we next examined how the presentation of novel objects affected sleep in AppNL-G-F/wt and AppNL-G-F/NL-G-F mice. Sleep was recorded from these mice and WT control mice for 4 h on exposure to novel objects at six and 12 months (Fig. 4). At both ages, similar to undisturbed sleep, the REMS/total sleep ratio was reduced in the homozygous mice (Fig. 4A). In addition, the REMS latency was decreased in the homozygous mice at six months (Fig. 4C). Thus, under specific conditions, the first episode of NREMS was shortened in these mice.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

AppNL-G-F/NL-G-F mice exhibit reduced REMS following exposure to novel objects. A, Total amount of wake, NREMS, REMS, and ratio of REMS to total sleep following presentation of novel objects. B, C, Latency to sleep (B) or REMS (C) following presentation of novel objects; *p < 0.05, Games–Howell multiple comparison test. Bar graphs represent mean ± SEM. Each point represents an individual mouse. Detailed results of the statistical tests are described in Extended Data Figure 4-1.

Extended Data Figure 4-1

Detailed results of the statistical analyses in Figure 4. Download Figure 4-1, XLSX file.

Learning and memory impairment in single App knock-in mice is associated with REMS deficits

Both sleep impairment and cognitive decline are commonly associated with the clinical stage of AD (Prinz et al., 1982; McCurry et al., 1999; Liguori et al., 2014). The AppNL-G-F/NL-G-F mice exhibited various age-dependent sleep deficits, especially in REMS. Here, we addressed whether the detected REMS defects were associated with learning and memory impairments. To investigate the correlation between sleep parameters and learning and memory performance at the individual level, the mice used in the sleep study were also subjected to a learning task. The FC task is a commonly used memory task in which an aversive US (foot-shock) is associated with some CS, typically a visual or an auditory cue. AppNL-G-F/NL-G-F mice are reported to perform normally in a contextual FC protocol, even at 15–18 months of age (Sakakibara et al., 2018). Here, we focused on trace FC. The trace FC is another hippocampus-dependent learning paradigm (McEchron et al., 1998; Quinn et al., 2002) that assesses temporal associative memory. In trace FC, a temporal gap is set between the CS (auditory tone) and the US (Huerta et al., 2000; Misane et al., 2005). Association of the temporally separated CS and US requires brain areas that are not essential for the delay FC (in which there is no gap between the CS and US), including the hippocampus and the prefrontal cortex (Gilmartin and Helmstetter, 2010). On day 1, the CS followed by the US was administered five times to mice at either seven or 13 months of age. Importantly, in all genotypes, the first US evoked a similar increase in movement, indicating that the sensitivity to the US itself was unaltered (Fig. 5A). At seven months, both the heterozygous and homozygous mice normally learned the association between the CS and US on day 1, as assessed by a gradual increase in the freezing rate during the CS (Fig. 5B). On day 2, the freezing rate following exposure to the tone was reduced in the homozygous mice compared with the WT control mice, suggesting impaired retention or recall of the memory (Fig. 5C). At 13 months, the homozygous mice, and to a lesser extent the heterozygous mice, exhibited learning impairment on day 1 compared with the WT control (Fig. 5B). The homozygous mice also exhibited a trend toward a reduction in the freezing rate on day 2 (Fig. 5C).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Impaired performance of AppNL-G-F/NL-G-F mice in trace FC. A, Movement of each seven-month-old and 13-month-old mouse before and during the first US; ###p < 0.001, mixed ANOVA. B, Percent time spent freezing during habituation or CS on day 1 (training). Each point represents mean ± SEM; ##p < 0.01, ###p < 0.001, mixed ANOVA; *p < 0.05, **p < 0.01, post hoc Games–Howell multiple comparison test. C, Percent time spent freezing during CS on day 2 (retrieval). Bar graphs represent the mean ± SEM. Each point represents an individual mouse; *p < 0.05, Games–Howell multiple comparison test. Detailed results of the statistical tests are described in Extended Data Figure 5-1.

Extended Data Figure 5-1

Detailed results of the statistical analyses in Figure 5. Download Figure 5-1, XLSX file.

To address whether the learning and memory deficits were associated with the sleep abnormalities, we performed correlation analyses between various sleep parameters and the freezing rate in the trace FC test (Fig. 6). The freezing rate during the third CS on day 1, which was reduced in the 13-month-old homozygous mice and had apparently not yet reached a plateau in the control WT mice, strongly and positively correlated with the total time in REMS (Fig. 6O). A similar trend was observed for the freezing rate on day 2 (Fig. 6U). By contrast, in the seven-month-old mice, although deficits in both REMS and trace FC were observed in the homozygous mice, no significant correlation was detected between the freezing rates and any sleep parameters tested (Fig. 6C,F,I,L), suggesting a specific correlation of the learning ability with REMS duration at the older age. We detected no significant correlation between the freezing rates and any sleep parameters tested in AppNL-G-F/wt or WT mice (Fig. 6).

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Correlations between the amount of time spent in each sleep stage and the performance in trace FC. A–L, Correlation between the total amount of REMS or NREMS and the percent time spent freezing either during the third CS on day 1 (training) or during CS on day 2 (retrieval) in WT, AppNL-G-F/wt and AppNL-G-F/NL-G-F mice of the younger age. M–X, Correlation between the total amount of REMS or NREMS and the percent time spent freezing either during the third CS on day 1 (training) or during CS on day 2 (retrieval) in WT, AppNL-G-F/wt and AppNL-G-F/NL-G-F mice of the older age. Each point represents an individual mouse. The line in each graph represents the regression line. Pearson’s correlation coefficient (r) and p value are provided.

Accumulation of Aβ in brain regions involved in REMS regulation

Amyloidosis does not proceed in a uniform manner across all brain areas. One critical advantage of the AD mouse model used in this study is that the App expression is predicted to faithfully recapitulate the endogenous pattern (Sasaguri et al., 2017). Thus, we next addressed Aβ accumulation in brain areas related to REMS in these mice. First, consistent with previous reports (Saito et al., 2014; Whyte et al., 2018), Aβ accumulation in the hippocampus and cortex increased with age in both the homozygous and heterozygous mice (Fig. 7C,D,J,K). The major sleep defect detected in the current study occurred during REMS. Many studies describe a crucial role of the brainstem in REMS regulation, especially the pontine tegmental area and the ventral medulla (Sakai et al., 2001; Boissard et al., 2002; Lu et al., 2006; Hayashi et al., 2015; Weber et al., 2015).

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Aβ deposition in brain areas related to REMS regulation in AppNL-G-F/wt and AppNL-G-F/NL-G-F mice. A–H, Representative images of brain sections immunostained for Aβ. Images in B, D, F, H are higher magnifications of the areas enclosed in A, C, E, G. Sections contain the following brain regions: MSDB (A, B), hippocampus and cortex (C, D), pontine tegmental area (E, F), and ventral medulla (G, H). Scale bar: 2.5 mm (A, C, E, G) and 1.0 mm (B, D, F, H). I–M, Quantification of Aβ plaque areas in MSDB (I), hippocampus (J), cortex (K), pontine tegmental area (L), and ventral medulla (M). Bar graphs represent the mean ± SEM. Each point represents an individual mouse; *p < 0.05, **p < 0.01, Welch’s t test. Detailed results of the statistical tests are described in Extended Data Figure 7-1.

Extended Data Figure 7-1

Detailed results of the statistical analyses in Figure 7. Download Figure 7-1, XLSX file.

Aβ seemed to accumulate in these brainstem areas in a manner different from that in the hippocampus and cortex. In these areas, Aβ accumulation largely increased from seven to 13 months in the homozygous mice, whereas it was hardly detectable in the heterozygous mice, a pattern that somewhat resembled the progression of the REMS impairment (Fig. 7E,F,G,H,L,M). The basal forebrain cholinergic neurons also contribute to sleep-wake regulation and are well known to be damaged in AD (Whitehouse et al., 1981, 1982; Lee et al., 2005; Ozen Irmak and de Lecea, 2014; Xu et al., 2015). Among these neurons, cholinergic neurons in the MSDB project to the hippocampus and are involved in oscillatory activity, neurogenesis, and learning and memory (Yoder and Pang, 2005; Hasselmo, 2006; Zhu et al., 2017). Aβ accumulation in the MSDB also appeared to progress in a manner different from that in the hippocampus or cortex, with comparable levels in the homozygous mice at seven and 13 months and in the heterozygous mice at 13 months (Fig. 7A–D,I–K).

Discussion

This is the first study to describe the sleep abnormalities exhibited by AppNL-G-F homozygous and heterozygous mice and the association of these sleep abnormalities with learning ability. Sleep is regulated by various brain areas and neuronal subtypes. Thus, addressing the association between sleep and AD using mouse models that overexpress or ectopically express APP or presenilin could complicate interpretations. Unlike previous studies in which the applied mouse models carried either multiple copies of App or presenilin or use heterologous promoters to express these genes, the present study used a mouse model in which mutated App was singly knocked into the original App locus. Indeed, homozygous mice faithfully recapitulated several aspects of the sleep abnormalities associated with preclinical or early AD. First, the amount of REMS was decreased from an early age, when no changes in the amount of wake or NREMS were detected. This is consistent with a recent prospective study in humans showing that the reduction in the total time spent in REMS, but not in NREMS, is associated with a higher risk for AD (Pase et al., 2017). Second, during REMS, slow oscillatory activity was increased while fast oscillatory activity was decreased. Again, studies of patients with early-stage AD or mild cognitive impairment report a similar shift in oscillatory activity during REMS (Prinz et al., 1992; Petit et al., 1993; Brayet et al., 2016). Thus, we believe the AppNL-G-F knock-in mouse is highly useful for elucidating the mechanisms underlying sleep deficits in AD.

The sleep architecture in the homozygous mice at six months of age was characterized by a decrease in REMS. At 12 months of age, the reduction of REMS was further pronounced, and NREMS was also reduced. By contrast, the sleep architecture of the heterozygous mice appeared mostly normal, even at 12 months of age. This might be explained by the time course of Aβ accumulation in brain areas crucial for REM sleep regulation. Accumulating evidence supports an essential role of the pontine tegmental area and ventral medulla in regulating REMS (Sakai et al., 2001; Boissard et al., 2002; Lu et al., 2006; Hayashi et al., 2015; Weber et al., 2015). In these two areas, in contrast to the hippocampus or cortex, Aβ was almost undetectable in the heterozygous mice. On the other hand, in the homozygous mice, Aβ in these two areas increased with age, consistent with the progressive decrease in REMS. Therefore, damage to the brainstem might be critical for the development of sleep deficits in AD. Recent studies also point to the roles of these areas in regulating NREMS, which might account for the decrease in NREMS at later stages (Anaclet et al., 2014; Hayashi et al., 2015). The basal forebrain cholinergic neurons are commonly damaged in AD and are involved in sleep-wake regulation (Whitehouse et al., 1981, 1982; Lee et al., 2005; Ozen Irmak and de Lecea, 2014; Xu et al., 2015). The time course of the Aβ accumulation in the MSDB of the basal forebrain, which contains many cholinergic neurons projecting to the hippocampus, in both the heterozygous and homozygous mice appeared not to be strongly correlated with the progression in sleep impairment. In addition to the brainstem and MSDB, various brain areas, including the hypothalamus and midbrain, are involved in sleep regulation. Further studies are required to determine damage to which neurons largely contributes to the sleep deficits. While the reduction in REMS at the younger age in the homozygous mice was consistent with human studies on preclinical or early stages of AD (Prinz et al., 1982; Pase et al., 2017), the reduction in the ratio of deep NREMS (stage 3 or 4), which is especially prominent in the advanced stages of AD (Prinz et al., 1982), was not obvious in the homozygous mice. Even at the older age, the homozygous mice exhibited normal δ power, although the total amount of NREMS was reduced. Thus, the homozygous mice, although an excellent model for preclinical or early stages of AD, might not recapitulate the sleep impairments that emerge in the advanced stages of the disease. In addition, there are also reports that patients with mild cognitive impairment, part of which will likely develop AD, exhibit reduction in the time spent in both REMS and deep NREMS (Westerberg et al., 2012), suggesting that sleep impairments accompanying AD are not uniform. It would be interesting to evaluate the relation between sleep impairment and the accumulation of Aβ in the pontine tegmental area and ventral medulla in patients with various stages of AD in future studies.

According to the results of cortical EEG spectral analyses in AD patients or patients with mild cognitive impairment, alterations in the oscillatory activity during REMS are suggested to be more sensitive biological markers of the disease than alterations during wake (Petit et al., 1993; Brayet et al., 2016). In such patients, EEG slowing, i.e., the simultaneous occurrence of an increase in the power of the slow (e.g., δ) component and a decrease in the power of the fast (e.g., α or β) component of the EEG power spectrum during REM sleep was observed. The homozygous mice in our study appeared to well recapitulate the EEG slowing during REMS, which, to our knowledge, is the first report of this in an AD mouse model. By contrast, some other AD mouse models exhibit an apparently opposite phenotype, i.e., a decrease in δ or θ power and an increase in γ power (Zhang et al., 2005; Jyoti et al., 2010; Schneider et al., 2014; Colby-Milley et al., 2015; Kent et al., 2018). Cortical and hippocampal oscillatory activities are regulated by both local circuits and various subcortical areas, including the brainstem. The altered oscillatory activities again highlight the advantage of using a single App knock-in mouse, in which the endogenous expression pattern of APP is faithfully recapitulated. For example, ectopic expression or overexpression of APP might lead to impaired inhibitory neurotransmission, considering that secreted APP can act on GABA B receptors (Rice et al., 2019). Of note, in another study using AppNL-G-F homozygous mice, local field potential measurements with tetrodes from the entorhinal cortex in awake behaving mice detected impaired γ-θ coupling as early as five months (Nakazono et al., 2017). Thus, in future studies, measurements of neural activity during REM sleep with similar devices and analyses may allow for the detection of impaired oscillations at an even earlier age.

According to recent studies, AppNL-G-F homozygous and heterozygous mice exhibit fairly mild behavioral defects, consistent with the notion that these mice represent a preclinical or early stage of AD. For example, homozygous mice perform normally in the contextual FC test, a spatial hippocampal-dependent task, even at 15–18 months (Sakakibara et al., 2018). In the current study, using trace FC, which assesses temporal associative memory, we were able to detect a memory deficit in homozygous mice at seven months. At 13 months, homozygous mice, and to a lesser extent, heterozygous mice exhibited impaired learning. Interestingly, at seven months, there was no correlation between the amount of REMS and learning or memory, whereas at 13 months, there was a strong and positive correlation. Perhaps, the memory deficit and REMS impairment originally develop independently at younger ages, but in the course of disease progression, somehow REMS impairment contributes to worsening of the learning and memory deficit. Postlearning REMS is crucial for memory consolidation (Boyce et al., 2016). As the 13-month-old heterozygous and homozygous mice displayed learning impairments during training, however, it is unlikely that defects of the postlearning sleep are the major cause. Therefore, if the REMS impairment does contribute to learning and memory deficits, it might be that REMS is somehow involved in the daily maintenance of the brain areas related to learning. Whereas recent studies have begun to elucidate the roles of NREMS in brain maintenance, e.g., by enhancing clearance of metabolites or by downscaling synaptic excitability (Xie et al., 2013; Norimoto et al., 2018), the contribution of REMS is far less understood. Future studies should address the possibility that impairments in REMS affect brain maintenance and contribute to the progression of AD.

Acknowledgments

Acknowledgement: We thank Kazushi Maruo for advice regarding the statistics and Natsu Hasegawa for technical assistance.

Footnotes

  • The authors declare no competing financial interests.

  • This study was supported by Japan Agency for Medical Research and Development (AMED) Grants JP19dm0107138 and JP19gm1110008, the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) World Premier International Research Center Initiative (WPI) Program, the Cell Science Research Foundation, the Asahi Glass Foundation, the Nakajima Foundation, the Senri Life Science Foundation, the Kanae Foundation for the Promotion of Medical Science, and the Japan Foundation for Applied Enzymology (TMFC) (Y.H.).

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Anaclet C, Ferrari L, Arrigoni E, Bass CE, Saper CB, Lu J, Fuller PM (2014) The GABAergic parafacial zone is a medullary slow wave sleep-promoting center. Nat Neurosci 17:1217–1224. doi:10.1038/nn.3789 pmid:25129078
    OpenUrlCrossRefPubMed
  2. ↵
    Arruda-Carvalho M, Sakaguchi M, Akers KG, Josselyn SA, Frankland PW (2011) Posttraining ablation of adult-generated neurons degrades previously acquired memories. J Neurosci 31:15113–15127. doi:10.1523/JNEUROSCI.3432-11.2011 pmid:22016545
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Boissard R, Gervasoni D, Schmidt MH, Barbagli B, Fort P, Luppi PH (2002) The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study. Eur J Neurosci 16:1959–1973. doi:10.1046/j.1460-9568.2002.02257.x pmid:12453060
    OpenUrlCrossRefPubMed
  4. ↵
    Boyce R, Glasgow SD, Williams S, Adamantidis A (2016) Causal evidence for the role of REM sleep theta rhythm in contextual memory consolidation. Science 352:812–816. doi:10.1126/science.aad5252 pmid:27174984
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Brayet P, Petit D, Frauscher B, Gagnon JF, Gosselin N, Gagnon K, Rouleau I, Montplaisir J (2016) Quantitative EEG of rapid-eye-movement sleep: a marker of amnestic mild cognitive impairment. Clin EEG Neurosci 47:134–141. doi:10.1177/1550059415603050 pmid:26323578
    OpenUrlCrossRefPubMed
  6. ↵
    Carpenter BD, Strauss M, Patterson MB (1996) Sleep disturbances in community-dwelling patients with Alzheimer’s disease. Clin Gerontol 16:35–49. doi:10.1300/J018v16n02_04
    OpenUrlCrossRef
  7. ↵
    Chowdhury N, Quinn JJ, Fanselow MS (2005) Dorsal hippocampus involvement in trace fear conditioning with long, but not short, trace intervals in mice. Behav Neurosci 119:1396–1402. doi:10.1037/0735-7044.119.5.1396 pmid:16300446
    OpenUrlCrossRefPubMed
  8. ↵
    Colby-Milley J, Cavanagh C, Jego S, Breitner JCS, Quirion R, Adamantidis A (2015) Sleep-wake cycle dysfunction in the TgCRND8 mouse model of Alzheimer’s disease: from early to advanced pathological stages. PLoS One 10:e0130177. doi:10.1371/journal.pone.0130177 pmid:26076358
    OpenUrlCrossRefPubMed
  9. ↵
    DeVos SL, Corjuc BT, Commins C, Dujardin S, Bannon RN, Corjuc D, Moore BD, Bennett RE, Jorfi M, Gonzales JA, Dooley PM, Roe AD, Pitstick R, Irimia D, Frosch MP, Carlson GA, Hyman BT (2018) Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo. Brain 141:2194–2212. doi:10.1093/brain/awy117 pmid:29733334
    OpenUrlCrossRefPubMed
  10. ↵
    Gilmartin MR, Helmstetter FJ (2010) Trace and contextual fear conditioning require neural activity and NMDA receptor-dependent transmission in the medial prefrontal cortex. Learn Mem 17:289–296. doi:10.1101/lm.1597410 pmid:20504949
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Hasselmo ME (2006) The role of acetylcholine in learning and memory. Curr Opin Neurobiol 16:710–715. doi:10.1016/j.conb.2006.09.002 pmid:17011181
    OpenUrlCrossRefPubMed
  12. ↵
    Hayashi Y, Kashiwagi M, Yasuda K, Ando R, Kanuka M, Sakai K, Itohara S (2015) Cells of a common developmental origin regulate REM/non-REM sleep and wakefulness in mice. Science 350:957–961. doi:10.1126/science.aad1023 pmid:26494173
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Herrmann CS, Demiralp T (2005) Human EEG gamma oscillations in neuropsychiatric disorders. Clin Neurophysiol 116:2719–2733. doi:10.1016/j.clinph.2005.07.007 pmid:16253555
    OpenUrlCrossRefPubMed
  14. ↵
    Huerta PT, Sun LD, Wilson MA, Tonegawa S (2000) Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons. Neuron 25:473–480. doi:10.1016/S0896-6273(00)80909-5 pmid:10719900
    OpenUrlCrossRefPubMed
  15. ↵
    Ju YES, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, Morris JC, Holtzman DM (2013) Sleep quality and preclinical Alzheimer disease. JAMA Neurol 70:587–593. doi:10.1001/jamaneurol.2013.2334 pmid:23479184
    OpenUrlCrossRefPubMed
  16. ↵
    Jyoti A, Plano A, Riedel G, Platt B (2010) EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer’s disease mouse. J Alzheimers Dis 22:873–887. doi:10.3233/JAD-2010-100879
    OpenUrlCrossRefPubMed
  17. ↵
    Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (2009) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326:1005–1007. doi:10.1126/science.1180962 pmid:19779148
    OpenUrlCrossRefPubMed
  18. ↵
    Kent BA, Strittmatter SM, Nygaard HB (2018) Sleep and EEG power spectral analysis in three transgenic mouse models of Alzheimer’s disease: APP/PS1, 3xTgAD, and Tg2576. J Alzheimers Dis 64:1325–1336. doi:10.3233/JAD-180260 pmid:29991134
    OpenUrlCrossRefPubMed
  19. ↵
    Koenig T, Prichep L, Dierks T, Hubl D, Wahlund LO, John ER, Jelic V (2005) Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 26:165–171. doi:10.1016/j.neurobiolaging.2004.03.008 pmid:15582746
    OpenUrlCrossRefPubMed
  20. ↵
    Lee MG, Hassani OK, Alonso A, Jones BE (2005) Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. J Neurosci 25:4365–4369. doi:10.1523/JNEUROSCI.0178-05.2005 pmid:15858062
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Liguori C, Romigi A, Nuccetelli M, Zannino S, Sancesario G, Martorana A, Albanese M, Mercuri NB, Izzi F, Bernardini S, Nitti A, Sancesario GM, Sica F, Marciani MG, Placidi F (2014) Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol 71:1498–1505. doi:10.1001/jamaneurol.2014.2510
    OpenUrlCrossRef
  22. ↵
    Lu J, Sherman D, Devor M, Saper CB (2006) A putative flip–flop switch for control of REM sleep. Nature 441:589–594. doi:10.1038/nature04767 pmid:16688184
    OpenUrlCrossRefPubMed
  23. ↵
    McCurry SM, Logsdon RG, Teri L, Gibbons LE, Kukull WA, Bowen JD, McCormick WC, Larson EB (1999) Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. J Geriatr Psychiatry Neurol 12:53–59. doi:10.1177/089198879901200203 pmid:10483925
    OpenUrlCrossRefPubMed
  24. ↵
    McEchron MD, Bouwmeester H, Tseng W, Weiss C, Disterhoft JF (1998) Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning in the rat. Hippocampus 8:638–646. doi:10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q
    OpenUrlCrossRefPubMed
  25. ↵
    Minakawa EN, Miyazaki K, Maruo K, Yagihara H, Fujita H, Wada K, Nagai Y (2017) Chronic sleep fragmentation exacerbates amyloid β deposition in Alzheimer’s disease model mice. Neurosci Lett 653:362–369. doi:10.1016/j.neulet.2017.05.054 pmid:28554860
    OpenUrlCrossRefPubMed
  26. ↵
    Misane I, Tovote P, Meyer M, Spiess J, Ogren SO, Stiedl O (2005) Time-dependent involvement of the dorsal hippocampus in trace fear conditioning in mice. Hippocampus 15:418–426. doi:10.1002/hipo.20067 pmid:15669102
    OpenUrlCrossRefPubMed
  27. ↵
    Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA (2005) Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Med 6:347–352. doi:10.1016/j.sleep.2004.12.005 pmid:15978517
    OpenUrlCrossRefPubMed
  28. ↵
    Nakazono T, Lam TN, Patel AY, Kitazawa M, Saito T, Saido TC, Igarashi KM (2017) Impaired in vivo gamma oscillations in the medial entorhinal cortex of knock-in Alzheimer model. Front Syst Neurosci 11:1–12.
    OpenUrlCrossRef
  29. ↵
    Norimoto H, Makino K, Gao M, Shikano Y, Okamoto K, Ishikawa T, Sasaki T, Hioki H, Fujisawa S, Ikegaya Y (2018) Hippocampal ripples down-regulate synapses - supplementary info. Science 359:1524–1528. doi:10.1126/science.aao0702
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Ozen Irmak S, de Lecea L (2014) Basal forebrain cholinergic modulation of sleep transitions. Sleep 37:1941–1951. doi:10.5665/sleep.4246 pmid:25325504
    OpenUrlCrossRefPubMed
  31. ↵
    Pase MP, Himali JJ, Grima NA, Beiser AS, Satizabal CL, Aparicio HJ, Thomas RJ, Gottlieb DJ, Auerbach SH, Seshadri S (2017) Sleep architecture and the risk of incident dementia in the community. Neurology 89:1244–1250. doi:10.1212/WNL.0000000000004373 pmid:28835407
    OpenUrlCrossRefPubMed
  32. ↵
    Petit D, Lorrain D, Gauthier S, Montplaisir J (1993) Regional spectral analysis of the REM sleep EEG in mild to moderate Alzheimer’s disease. Neurobiol Aging 14:141–145. doi:10.1016/0197-4580(93)90089-t pmid:8487916
    OpenUrlCrossRefPubMed
  33. ↵
    Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A, Utan A, Merrick G, Ryan D, Melis V, Wan H, Mingarelli M, Porcu E, Scrocchi L, Welch A, Riedel G (2011) Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, plb1. PLoS One 6:e27068. doi:10.1371/journal.pone.0027068
    OpenUrlCrossRefPubMed
  34. ↵
    Prinz PN, Vitaliano PP, Vitiello MV, Bokan J, Raskind M, Peskind E, Gerber C (1982) Sleep, EEG and mental function changes in senile dementia of the Alzheimer’s type. Neurobiol Aging 3:361–370. doi:10.1016/0197-4580(82)90024-0 pmid:7170052
    OpenUrlCrossRefPubMed
  35. ↵
    Prinz PN, Larsen LH, Moe KE, Vitiello MV (1992) EEG markers of early Alzheimer’s disease in computer selected tonic REM sleep. Electroencephalogr Clin Neurophysiol 83:36–43. doi:10.1016/0013-4694(92)90130-A pmid:1376664
    OpenUrlCrossRefPubMed
  36. ↵
    Purple RJ, Sakurai T, Sakaguchi M (2017) Auditory conditioned stimulus presentation during NREM sleep impairs fear memory in mice. Sci Rep 7:46247. doi:10.1038/srep46247 pmid:28401950
    OpenUrlCrossRefPubMed
  37. ↵
    Quinn JJ, Oommen SS, Morrison GE, Fanselow MS (2002) Post-training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner. Hippocampus 12:495–504. doi:10.1002/hipo.10029 pmid:12201634
    OpenUrlCrossRefPubMed
  38. ↵
    Rice HC, de Malmazet D, Schreurs A, Frere S, Van Molle I, Volkov AN, Creemers E, Vertkin I, Nys J, Ranaivoson FM, Comoletti D, Savas JN, Remaut H, Balschun D, Wierda KD, Slutsky I, Farrow K, De Strooper B, de Wit J (2019) Secreted amyloid-β precursor protein functions as a GABA B R1a ligand to modulate synaptic transmission. Science 363:eaao4827. doi:10.1126/science.aao4827
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, Holtzman DM (2012) Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer’s disease pathology. Sci Transl Med 4:150ra122. doi:10.1126/scitranslmed.3004291 pmid:22956200
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC (2014) Single App knock-in mouse models of Alzheimer’s disease. Nat Neurosci 17:661–663. doi:10.1038/nn.3697 pmid:24728269
    OpenUrlCrossRefPubMed
  41. ↵
    Sakai K, Crochet S, Onoe H (2001) Pontine structures and mechanisms involved in the generation of paradoxical (REM) sleep. Arch Ital Biol 139:93–107. pmid:11256190
    OpenUrlPubMed
  42. ↵
    Sakakibara Y, Sekiya M, Saito T, Saido TC, Iijima KM (2018) Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. BMC Neurosci 19:46. doi:10.1186/s12868-018-0446-8 pmid:30055565
    OpenUrlCrossRefPubMed
  43. ↵
    Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, Hardy J, Vassar R, Winblad B, Saido TC (2017) APP mouse models for Alzheimer’s disease preclinical studies. EMBO J 36:2473–2487. doi:10.15252/embj.201797397 pmid:28768718
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Schiffelholz T, Aldenhoff JB (2002) Novel object presentation affects sleep-wake behavior in rats. Neurosci Lett 328:41–44. doi:10.1016/s0304-3940(02)00452-4 pmid:12123855
    OpenUrlCrossRefPubMed
  45. ↵
    Schneider F, Baldauf K, Wetzel W, Reymann KG (2014) Behavioral and EEG changes in male 5xFAD mice. Physiol Behav 135:25–33. doi:10.1016/j.physbeh.2014.05.041 pmid:24907698
    OpenUrlCrossRefPubMed
  46. ↵
    Seibenhener ML, Wooten MC (2015) Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp 96:e52434. doi:10.3791/52434
    OpenUrlCrossRefPubMed
  47. ↵
    Sethi M, Joshi SS, Webb RL, Beckett TL, Donohue KD, Murphy MP, O’Hara BF, Duncan MJ (2015) Increased fragmentation of sleep–wake cycles in the 5XFAD mouse model of Alzheimer’s disease. Neuroscience 290:80–89. doi:10.1016/j.neuroscience.2015.01.035
    OpenUrlCrossRef
  48. ↵
    Shokri-Kojori E, Wang G-J, Wiers CE, Demiral SB, Guo M, Kim SW, Lindgren E, Ramirez V, Zehra A, Freeman C, Miller G, Manza P, Srivastava T, De Santi S, Tomasi D, Benveniste H, Volkow ND (2018) β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci USA 115:4483–4488. doi:10.1073/pnas.1721694115 pmid:29632177
    OpenUrlAbstract/FREE Full Text
  49. ↵
    Weber F, Chung S, Beier KT, Xu M, Luo L, Dan Y (2015) Control of REM sleep by ventral medulla GABAergic neurons. Nature 526:435–438. doi:10.1038/nature14979 pmid:26444238
    OpenUrlCrossRefPubMed
  50. ↵
    Westerberg CE, Mander BA, Florczak SM, Weintraub S, Mesulam M-M, Zee PC, Paller KA (2012) Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. J Int Neuropsychol Soc 18:490–500. doi:10.1017/S135561771200001X pmid:22300710
    OpenUrlCrossRefPubMed
  51. ↵
    Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122–126. doi:10.1002/ana.410100203 pmid:7283399
    OpenUrlCrossRefPubMed
  52. ↵
    Whitehouse P, Price D, Struble R, Clark A, Coyle J, Delon M (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239. doi:10.1126/science.7058341 pmid:7058341
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Whyte LS, Hemsley KM, Lau AA, Hassiotis S, Saito T, Saido TC, Hopwood JJ, Sargeant TJ (2018) Reduction in open field activity in the absence of memory deficits in the AppNL-G-F knock-in mouse model of Alzheimer’s disease. Behav Brain Res 336:177–181. doi:10.1016/j.bbr.2017.09.006 pmid:28887197
    OpenUrlCrossRefPubMed
  54. ↵
    Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342:373–377. doi:10.1126/science.1241224 pmid:24136970
    OpenUrlAbstract/FREE Full Text
  55. ↵
    Xu M, Chung S, Zhang S, Zhong P, Ma C, Chang WC, Weissbourd B, Sakai N, Luo L, Nishino S, Dan Y (2015) Basal forebrain circuit for sleep-wake control. Nat Neurosci 18:1641–1647. doi:10.1038/nn.4143 pmid:26457552
    OpenUrlCrossRefPubMed
  56. ↵
    Yoder RM, Pang KCH (2005) Involvement of GABAergic and cholinergic medial septal neurons in hippocampal theta rhythm. Hippocampus 15:381–392. doi:10.1002/hipo.20062 pmid:15630696
    OpenUrlCrossRefPubMed
  57. ↵
    Zhang B, Veasey SC, Wood MA, Leng LZ, Kaminski C, Leight S, Abel T, Lee V-Y, Trojanowski JQ (2005) Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer’s disease with injury to pedunculopontine cholinergic neurons. Am J Pathol 167:1361–1369. doi:10.1016/S0002-9440(10)61223-0 pmid:16251420
    OpenUrlCrossRefPubMed
  58. ↵
    Zhu H, Yan H, Tang N, Li X, Pang P, Li H, Chen W, Guo Y, Shu S, Cai Y, Pei L, Liu D, Luo M-H, Man H, Tian Q, Mu Y, Zhu L-Q, Lu Y (2017) Impairments of spatial memory in an Alzheimer’s disease model via degeneration of hippocampal cholinergic synapses. Nat Commun 8:1676. doi:10.1038/s41467-017-01943-0 pmid:29162816
    OpenUrlCrossRefPubMed

Synthesis

Reviewing Editor: Bong-Kiun Kaang, Seoul National University

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. Note: If this manuscript was transferred from JNeurosci and a decision was made to accept the manuscript without peer review, a brief statement to this effect will instead be what is listed below.

I agree with the responses that were made by the author. The manuscript should be published as it is.

Back to top

In this issue

eneuro: 7 (2)
eNeuro
Vol. 7, Issue 2
March/April 2020
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Progressive Changes in Sleep and Its Relations to Amyloid-β Distribution and Learning in Single App Knock-In Mice
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Progressive Changes in Sleep and Its Relations to Amyloid-β Distribution and Learning in Single App Knock-In Mice
Sakura Eri B. Maezono, Mika Kanuka, Chika Tatsuzawa, Miho Morita, Taizo Kawano, Mitsuaki Kashiwagi, Pimpimon Nondhalee, Masanori Sakaguchi, Takashi Saito, Takaomi C. Saido, Yu Hayashi
eNeuro 22 April 2020, 7 (2) ENEURO.0093-20.2020; DOI: 10.1523/ENEURO.0093-20.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Progressive Changes in Sleep and Its Relations to Amyloid-β Distribution and Learning in Single App Knock-In Mice
Sakura Eri B. Maezono, Mika Kanuka, Chika Tatsuzawa, Miho Morita, Taizo Kawano, Mitsuaki Kashiwagi, Pimpimon Nondhalee, Masanori Sakaguchi, Takashi Saito, Takaomi C. Saido, Yu Hayashi
eNeuro 22 April 2020, 7 (2) ENEURO.0093-20.2020; DOI: 10.1523/ENEURO.0093-20.2020
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Alzheimer’s disease
  • brainstem
  • electroencephalogram
  • learning and memory
  • mouse
  • sleep

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Capacity Limits Lead to Information Bottlenecks in Ongoing Rapid Motor Behaviors
  • Nonlinear Theta-Gamma Coupling between the Anterior Thalamus and Hippocampus Increases as a Function of Running Speed
  • Contrast and Luminance Gain Control in the Macaque’s Lateral Geniculate Nucleus
Show more Research Article: New Research

Disorders of the Nervous System

  • Characterization of the Tau Interactome in Human Brain Reveals Isoform-Dependent Interaction with 14-3-3 Family Proteins
  • Impaired AMPARs translocation into dendritic spines with motor skill learning in the Fragile X mouse model
  • Glycolytic System in Axons Supplement Decreased ATP Levels after Axotomy of the Peripheral Nerve
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.